Japanese scientists have made a breakthrough in the development of self-powered wearable biosensors with the creation of a printable enzyme ink that simplifies the mass production of enzymatic biofuel cells (EBFCs). This innovation, developed by a team led by Associate Professor Isao Shitanda from Tokyo University of Science, could pave the way for wearable devices that monitor health metrics in real time without requiring batteries.

Overcoming Manufacturing Challenges

Wearable sensors capable of tracking physiological signals such as lactate and glucose levels in sweat have long been a focus of research. However, most of these devices require external power sources to function. EBFCs, which use enzymes to convert body fluids into electricity, offer a promising alternative. Despite their potential, EBFCs have faced significant challenges in mass production due to the labor-intensive and inconsistent fabrication processes required.

Traditional methods involve printing a carbon electrode layer, then separately applying enzyme and mediator solutions, followed by drying. This multi-step process leads to variability in device performance, making quality control difficult and mass production impractical. To address these issues, the research team developed a water-based ‘enzyme ink’ that allows for the entire fabrication process to be completed in a single step.

Innovative Ink Formulation

The team’s ink formulation combines magnesium oxide-templated mesoporous carbon, which has a high surface area, with chemical mediators that facilitate electron transfer and a novel water-based binder called POLYSOL. This binder adheres strongly to carbon surfaces while maintaining a stable environment for enzymes. Carboxymethyl cellulose was added to achieve the right consistency for screen printing, and the specific enzymes needed for different biosensors, such as lactate oxidase and glucose dehydrogenase, were included.

The researchers printed these inks directly onto lightweight paper substrates using a single manufacturing step. Electrochemical tests showed that the printed electrodes outperformed conventional drop-cast methods, producing higher catalytic currents and maintaining stable performance over long periods. In contrast, drop-cast electrodes typically degrade to less than half their initial activity within minutes to hours, while the enzyme-ink electrodes showed minimal decay.

Real-World Applications and Performance

A complete lactate/oxygen biofuel cell assembled from these screen-printed electrodes achieved a maximum power output of 165 μW/cm with an operating voltage of 0.63 V, significantly higher than the 96 μW/cm previously reported. This represents a major breakthrough, as it is the first successful screen printing of the cathode side using enzyme ink.

The system is designed to measure lactate concentrations in sweat, accurately quantifying levels within the physiological range observed in healthy individuals (approximately 1-25 mM). This range is particularly relevant for monitoring exercise intensity and metabolic status. The researchers also confirmed that the generated power is sufficient to support Bluetooth Low Energy wireless transmission, demonstrating the feasibility of self-powered wireless monitoring of lactate concentration.

To showcase the scalability of the proposed solution, the team conducted a practical roll-to-roll printing demonstration, achieving continuous printing on 400 meters of substrate. This approach could enable very low-cost production—potentially around 10 yen per device—making the technology highly attractive for disposable or large-scale wearable applications.

“Together, our findings demonstrate that water-based enzyme ink formulations are a scalable, reproducible, and high-performance approach for fabricating EBFCs, offering practical advantages for integration into flexible, wearable, and self-powered biosensor platforms,” Dr. Shitanda said.

Looking ahead, the researchers aim for practical implementation around 2030. This timeline reflects the need for further device optimization, long-term validation, and integration with wearable platforms. While specific commercial partners have not yet been identified, the team anticipates that printing companies and healthcare device manufacturers may be strong candidates for adopting this technology.

The implications of this work are far-reaching. In sports, real-time sweat lactate monitoring could provide immediate feedback on exercise intensity and muscle fatigue. For nursing and elderly care, continuous metabolic monitoring could allow for the early detection of health conditions. Similar biosensors may also contribute to heatstroke prevention systems by detecting early metabolic warning signs.

“In these ways, this technology has the potential to contribute to the realization of a safer and healthier society by serving as the basis for sensors that monitor one’s physical condition by simply wearing them,” Dr. Shitanda concluded.